United States · Platforms & data · TipRanks
Innovent’s Zybrivo Receives Positive CHMP Opinion for First-Line NSCLC Treatment
Detailed summary
The latest announcement is out from Innovent Biologics ( (HK:1801) ).
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tipranks.com)




